Although DHF trades at an attractive discount to NAV valuation, I believe that the overall appeal is limited due to the ...

Very small clarification, Mohit, we saw the NCLT approval for MakeMyTrip and the redBus merger, which in a way sort of removes any legal or regulatory overhang from a potential India IPO point of view ...

Can you hit "reset" on your microbiome? In this newsletter, I’m going to explore what that reset might look like.